Dr. Jonathan Pollack

Biography

Dr. Pollack's research focuses on translational genomics with a major emphasis on prostate diseases. He is an original pioneer in array-based comparative genomic hybridization and has conducted early work on DNA copy number alterations, novel cancer genes, and transcriptional signatures in prostate and breast cancer. His recent studies utilize genomic approaches and gene editing in human cell and tissue models to examine benign urologic diseases, particularly benign prostatic hyperplasia (BPH), a noncancerous prostate enlargement in older men that leads to significant urinary problems. His studies have also covered rare cancer types such as ameloblastoma and liposarcoma. Dr. Pollack has received several prestigious awards, including the Amgen Outstanding Investigator Award from the American Society for Investigative Pathology in 2006, recognizing his significant contributions to experimental pathology. He was elected as a member of the American Society for Clinical Investigation and has authored 125 research publications. Dr. Pollack completed his undergraduate degree at Harvard College, followed by an MD and PhD in Biochemistry at the University of California, San Francisco, where he also undertook clinical pathology residency training. He joined the faculty at Stanford University in 2001 and has served as the founding Director of the Stanford Tissue Bank.

Research Interests

Experience

Awards

Courses